Paper78795
Antineoplastic drugs: clinical pharmacology and therapeutic use.
Bender RA and 8 others. Drugs, 1978. Cited by 42 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antineoplastic drugs: clinical pharmacology and therapeutic use. Papers, record 78795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/78795
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Alkaloids | |
| Alkylating Agents | |
| Antibiotics, Antineoplastic | |
| Azacitidine | |
| Bleomycin | |
| Cisplatin | |
| Cyclophosphamide | |
| Cytarabine | |
| Drug Interactions | |
| Fluorouracil | |
| Humans | |
| Kinetics | |
| Methotrexate | |
| Podophyllotoxin |
Source PubMed
References271
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,268,851 | The effect of adriamycin on the cell cycle traverse of a human lymphoid cell line. | Cancer Res | 1976 | https://conductscience.org/library/papers/1268851 | PubMed |
| 2 | 4,114,341 | Bleomycin therapy in advanced hodgkin's disease and epidermoid cancers. | Cancer | 1972 | https://conductscience.org/library/papers/4114341 | PubMed |
| 3 | 4,586,953 | Cis-diamminedichloroplatinum (NSC-119875): a phase I study. | Cancer Chemother Rep | 1973 | https://conductscience.org/library/papers/4586953 | PubMed |
| 4 | 942,583 | Clinical effects and pharmacokinetics of different dosage schedules of adriamycin. | Cancer Res | 1976 | https://conductscience.org/library/papers/942583 | PubMed |
| 5 | 1,157,447 | PTG, a new antineoplastic epipodyphyllotoxin. | Clin Pharmacol Ther | 1975 | https://conductscience.org/library/papers/1157447 | PubMed |
| 6 | 4,122,362 | A clinical review of bleomycin--a new antineoplastic agent. | Cancer | 1973 | https://conductscience.org/library/papers/4122362 | PubMed |
| 7 | 1,168,475 | Uptake and binding of vincristine by murine leukemia cells. | Biochem Pharmacol | 1975 | https://conductscience.org/library/papers/1168475 | PubMed |
| 8 | 884,658 | The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells. | Cancer Res | 1977 | https://conductscience.org/library/papers/884658 | PubMed |
| 9 | 872,088 | Pharmacokinetics of vindesine and vincristine in humans. | Cancer Res | 1977 | https://conductscience.org/library/papers/872088 | PubMed |
| 10 | 1,184,747 | Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion. | J Clin Invest | 1975 | https://conductscience.org/library/papers/1184747 | PubMed |
| 11 | 4,823,268 | Distribution and retention of the antitumor agent 195mPt-cis-dichlorodiammine platinum (II) in man. | J Nucl Med | 1974 | https://conductscience.org/library/papers/4823268 | PubMed |
| 12 | 5,092,856 | The effect of prednisolone and other factors on the catabolism of 5-fluorouracil in rats. | J Lab Clin Med | 1971 | https://conductscience.org/library/papers/5092856 | PubMed |
| 13 | 1,268,859 | Tumorigenicity in vivo and induction of malignant transformation and mutagenesis in cell cultures by adriamycin and daunomycin. | Cancer Res | 1976 | https://conductscience.org/library/papers/1268859 | PubMed |
| 14 | 4,634,038 | Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213). | Cancer Chemother Rep | 1972 | https://conductscience.org/library/papers/4634038 | PubMed |
| 15 | 5,349,626 | The effect of organic acids on renal clearance of methotrexate in man. | Clin Pharmacol Ther | 1969 | https://conductscience.org/library/papers/5349626 | PubMed |
| 16 | 1,273,807 | Adriamycin and fibrinolysis. | Thromb Res | 1976 | https://conductscience.org/library/papers/1273807 | PubMed |
| 17 | 4,578,134 | Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours. | Br Med J | 1973 | https://conductscience.org/library/papers/4578134 | PubMed |
| 18 | 766,582 | Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential. | Adv Cancer Res | 1975 | https://conductscience.org/library/papers/766582 | PubMed |
| 19 | 4,548,188 | The chemical and biological effects of cis-dichlorodiammineplatinum (II), an antitumor agent, on DNA. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4548188 | PubMed |
| 20 | 1,182,680 | Radiation-adriamycin interactions: preliminary clinical observations. | Cancer | 1975 | https://conductscience.org/library/papers/1182680 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,012,200 | Congo Red as a Supramolecular Carrier System for Doxorubicin: An Approach to Understanding the Mechanism of Action. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36012200 | PubMed |
| 7,031,350 | [Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)]. | Klin Wochenschr | 1981 | https://conductscience.org/library/papers/7031350 | PubMed |
| 6,680,116 | Modern cancer chemotherapy. | Indian J Pediatr | 1983 | https://conductscience.org/library/papers/6680116 | PubMed |
| 6,189,661 | Clinical pharmacokinetics of commonly used anticancer drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6189661 | PubMed |
| 3,839,754 | Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion doses. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3839754 | PubMed |
| 3,042,525 | Increase of corneal graft survival by use of topically immunosuppressive agents in rabbits. | Graefes Arch Clin Exp Ophthalmol | 1988 | https://conductscience.org/library/papers/3042525 | PubMed |
| 2,661,101 | Clinical pharmacokinetics-pharmacodynamics of anticancer drugs. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2661101 | PubMed |
| 2,656,050 | Clinical pharmacology of 5-fluorouracil. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2656050 | PubMed |
| 465,283 | Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/465283 | PubMed |
| 363,401 | Drug treatment of breast cancer. | Drugs | 1978 | https://conductscience.org/library/papers/363401 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/78795
GET https://conductscience.org/api/papers/v1/78795/references?page=2